Kolmar Group is a global innovator of cosmetics, pharmaceuticals, and health supplements.
In 1990, Kolmar Korea pioneered Original Development & Design Manufacturing (ODM) within the domestic cosmetics industry. Since then, the beauty innovator has expanded into subsidiaries such as Kolmar Korea, Inno.N, and Kolmar BNH to actively engage with the fields of pharmaceuticals, biotech, and health supplements.
Kolmar provides total-service research, development, and production to over 2,300 companies worldwide. Beginning with a revenue of 1 billion KRW in 1991, Kolmar has achieved significant growth, reaching 2.7124 trillion KRW in 2022. Today, we proudly lead the global beauty and bio-healthcare industries.
Kolmar Korea Holdings' business can be defined as the "Star Business Model," centering us as a global beauty and bio healthcare company that branches into cosmetics, pharmaceuticals, and healthy food supplements. Our client-centric approach and innovation-forward values allow us a holistic focus on the health and beauty of all humankind.
Kolmar Korea was the first to introduce an Original Development & Design Manufacturing (ODM) process into the Korean cosmetics industry. Backed by exceptional technology and high product quality, Kolmar Group provides complete service that encompasses trend analysis, product planning, development, production, and shipment. As a major brand company advocate, we support the global expansion of K-beauty.
Inno.N is Korea's leading pharmaceutical company, combining the Fourth Industrial Revolution technologies with biopharmaceuticals to pursue significant innovations in the advanced bio and healthcare fields. We invest our research capabilities in developing new drugs and vaccines to treat liver disease, cancers, immunological disorders, and infections. Korea's 30th new drug K-CAB Tab launched in 2019, a defining moment in the history of blockbuster medicines.
Kolmar BNH is the first public-private joint venture established by Kolmar Korea and the Korea Atomic Energy Research Institute, and is the first research institute to be registered with the Ministry of Science, ICT, and Future Planning. Innovations within the research and development of new materials derived from natural substances places Komar Group solidly at the forefront of the Korean health supplement market.
Seoul, South Korea
Incheon, South Korea
Incheon, South Korea
Seoul, South Korea
Incheon, South Korea
925 Griffin Pond RoadClarks
Summit, PA 18411
Wuxi, China
Beijing, China
Huizou, China
925 Griffin Pond RoadClarks
Summit, PA 18411
Teaneck, New Jersey
Olyphant, Pennsylvania
Barrie Ontario
